Los puntos clave no están disponibles para este artículo en este momento.
Pharmacotherapy is often severely hindered by issues related to poor drug selectivity, including side effects, environmental toxicity, and the emergence of resistance. Lack of selectivity is caused by the inability to control drug activity in time and space. Photopharmacology aims at solving this issue by incorporating photoswitchable groups into the molecular structure of bioactive compounds. These switching units allow for the use of light as an external control element for pharmacological activity, which can be delivered with very high spatiotemporal precision. This Perspective presents the reader with the current state and outlook on photopharmacology. In particular, the principles behind photoregulation of bioactivity, the challenges of molecular design, and the possible therapeutic scenarios are discussed.
Building similarity graph...
Analyzing shared references across papers
Loading...
Willem A. Velema
Radboud University Nijmegen
Wiktor Szymański
University Medical Center Groningen
Ben L. Feringa
University of Pisa
Journal of the American Chemical Society
University of Groningen
Building similarity graph...
Analyzing shared references across papers
Loading...
Velema et al. (Thu,) studied this question.
synapsesocial.com/papers/69d81457a2a48916bbbeeda1 — DOI: https://doi.org/10.1021/ja413063e
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: